2026-20748: Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction
Get alerted when the next rule lands
New rules open for comment on their own schedule. Pick how you want to hear about them — we email you when one appears.
Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.
Create a free account & build one →Summary
On August 12, 2026, the Drug Enforcement Administration (DEA) published a temporary order placing O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act. DEA published this temporary order that specifically noted in the summary that the control of O-desmethyltramadol included its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, however inadvertently omitted the correct language that should have been included. This document corrects that error, adding the correct language.
The agency’s own summary, as published.
The rule, in full
566 words as published, October 09, 2026. View the original →
Federal Register, Volume 91 Issue 195 (Friday, October 9, 2026) [Federal Register Volume 91, Number 195 (Friday, October 9, 2026)] [Rules and Regulations] [Pages 64617-64618] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2026-20748] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration 21 CFR Part 1308 [Docket No. DEA-1641] Schedules of Controlled Substances: Placement of O- Desmethyltramadol in Schedule I; Correction
Agency
Drug Enforcement Administration, Department of Justice.
Action
Correcting amendment. -----------------------------------------------------------------------
Summary
On August 12, 2026, the Drug Enforcement Administration (DEA) published a temporary order placing O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act. DEA published this temporary order that specifically noted in the summary that the control of O-desmethyltramadol included its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, however inadvertently omitted the correct language that should have been included. This document corrects that error, adding the correct language.
Dates
This correcting amendment is effective October 9, 2026, until August 12, 2028, and applicable beginning August 12, 2026.
For Further Information Contact
Dr. Terrence L. Boos, Drug and Chemical Evaluation Section, Diversion Control Division, Drug Enforcement Administration; Telephone: (571) 362-3249.
Supplementary Information
The placement of O-desmethyltramadol under schedule I was effective on August 12, 2026.\1\ After publication of the temporary scheduling order, DEA inadvertently omitted the correct language that should have been included in 21 CFR part 1308. This document corrects the language in 21 CFR part 1308 to include the isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible of O-desmethyltramadol. --------------------------------------------------------------------------- \1\ Schedules of Controlled Substances: Temporary Placement of O-desmethyltramadol in Schedule I, 91 FR 52013 (Aug. 12, 2026). --------------------------------------------------------------------------- List of Subjects in 21 CFR Part 1308 Administrative practice and procedure, Drug traffic control, Reporting and recordkeeping requirements. For the reasons set out above, DEA corrects 21 CFR part 1308 with the following correcting amendment: PART 1308--SCHEDULES OF CONTROLLED SUBSTANCES 0
1. The authority citation for part 1308 continues to read as follows:
Authority: 21 U.S.C. 811, 812, 871(b), 956(b), unless otherwise noted. 0
2. In Sec. 1308.11, revise paragraph (h)(88) to read as follows:
Sec. 1308.11 Schedule I. * * * * * (h) * * * ------------------------------------------------------------------------ ------------------------------------------------------------------------ * * * * * * * (88) O-desmethyltramadol, its isomers, esters, ethers, salts, 9667 and salts of isomers, esters and ethers (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol)..................................... * * * * * * * ------------------------------------------------------------------------ [[Page 64618]] Signing Authority This document of the Drug Enforcement Administration was signed on October 6, 2026, by DEA Administrator Terrance C. Cole. That document with the original signature and date is maintained by DEA. For administrative purposes only, and in compliance with requirements of the Office of the Federal Register, the undersigned DEA Federal Register Liaison Officer has been authorized to sign and submit the document in electronic format for publication, as an official document of DEA. This administrative process in no way alters the legal effect of this document upon publication in the Federal Register. Heather Achbach, Federal Register Liaison Officer, Drug Enforcement Administration. [FR Doc. 2026-20748 Filed 10-8-26; 8:45 am] BILLING CODE 4410-09-P
What this changes
Amends 1 part of the Code of Federal Regulations — the standing rules this notice rewrites.
Documents
- Full text (Federal Register) · October 09, 2026
Don't miss the comment window
One Click Politics alerts you on every deadline, hearing, and rule change.
See all rules with comments due soon →